These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8060196)
21. [Immunocorrection in the combined treatment of patients with osteomyelitis developing following combined injuries to the maxillofacial and craniocerebral areas]. Grigoriants LA; Zuev VP; Rakhmetov BR; Eremeev VV; Abramova ZP; Litvinova LL Stomatologiia (Mosk); 1991; (5):53-4. PubMed ID: 1798997 [TBL] [Abstract][Full Text] [Related]
22. [Morphofunctional characteristics of the immunocompetent system in hypotrophy and its correction by thymogen]. Khmel'nitskiĭ OK; Belianin VL; Kotov VA; Liutinskiĭ SI Arkh Patol; 1991; 53(10):24-7. PubMed ID: 1793373 [TBL] [Abstract][Full Text] [Related]
23. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals]. Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376 [TBL] [Abstract][Full Text] [Related]
24. [Treatment with thymogen and myelopid of patients with bronchial asthma]. Zoloedov VI; Zemskov AM; Stupnitskiĭ AA; Goriainova TA Klin Med (Mosk); 1995; 73(6):43-5. PubMed ID: 8691781 [TBL] [Abstract][Full Text] [Related]
25. [Thymogen in the treatment of type-1 diabetes mellitus]. Zhuk EA; Galenok VA Ter Arkh; 1996; 68(10):12-4. PubMed ID: 9026934 [TBL] [Abstract][Full Text] [Related]
26. [The combined therapy of chronic pyoderma taking into account body immunological reactivity and staphylococcal antibiotic resistance]. Rodionov AN; Khavinson VKh; Barbinov VV Voen Med Zh; 1992 Aug; (8):28-30. PubMed ID: 1441267 [TBL] [Abstract][Full Text] [Related]
28. [Immunocorrection in the combined treatment of patients with sialoadenitis]. Pinelis IS; Skurlatov AG Stomatologiia (Mosk); 1997; 76(1):32-3. PubMed ID: 9148512 [No Abstract] [Full Text] [Related]
29. Issues in the management of sexually transmitted diseases in Papua New Guinea. Passey M P N G Med J; 1996 Sep; 39(3):252-60. PubMed ID: 9795576 [TBL] [Abstract][Full Text] [Related]
30. [Changes of immune and non-specific reactivity in patients with chronic suppurative obstructive bronchitis in comprehensive treatment with thymogen]. Litvinova NV; Eremeev VV; Abramova ZP; Kulikovskaia NV; Gergert VIa Probl Tuberk; 1994; (4):48-50. PubMed ID: 7984617 [TBL] [Abstract][Full Text] [Related]
31. Pefloxacin and immunity: cellular uptake, potentiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae. Cuffini AM; Tullio V; Fazari S; Allocco A; Carlone NA Int J Tissue React; 1992; 14(3):131-9. PubMed ID: 1446977 [TBL] [Abstract][Full Text] [Related]
32. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. LeFevre ML; Ann Intern Med; 2014 Dec; 161(12):902-10. PubMed ID: 25243785 [TBL] [Abstract][Full Text] [Related]
33. [The effect of the synthetic immunomodulator thymogen on radiation-induced carcinogenesis in rats]. Anisimov VN; Miretskiĭ GI; Morozov VG; Pavel'eva IA; Khavinson VKh Vopr Onkol; 1992; 38(4):451-8. PubMed ID: 1300740 [TBL] [Abstract][Full Text] [Related]
34. Dual infection with Neisseria gonorrhoeae and Chlamydia trachomatis. Moss TR; Van Der Pol B Int J STD AIDS; 2009 Feb; 20(2):143-4. PubMed ID: 19182067 [No Abstract] [Full Text] [Related]
36. [Treatment of disorders in interferon status of patients with urogenital chlamydial infection]. Abidov AM; Saĭitkulov AM Lik Sprava; 2003; (3-4):81-4. PubMed ID: 12889367 [TBL] [Abstract][Full Text] [Related]
38. Expedited partner therapy for adolescents diagnosed with gonorrhea or chlamydia: a review and commentary. Hogben M; Burstein GR Adolesc Med Clin; 2006 Oct; 17(3):687-95; abstract xii. PubMed ID: 17030286 [TBL] [Abstract][Full Text] [Related]
39. CDC update on gonorrhea: expand treatment to limit resistance. Campos-Outcalt D J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356 [No Abstract] [Full Text] [Related]
40. [Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters]. Budanov SV; Vasil'ev AN; Smirnov LB Antibiot Khimioter; 2002; 47(12):31-6. PubMed ID: 12728632 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]